Current Drug Research Reviews
Title:Preface
Volume: 13 Issue: 1
Author(s): Ricardo Jorge Dinis-Oliveira
Affiliation:
Export Options
About this article
Cite this article as:
Dinis-Oliveira Jorge Ricardo, Preface, Current Drug Research Reviews 2021; 13 (1) . https://dx.doi.org/10.2174/258997751301210204144715
DOI https://dx.doi.org/10.2174/258997751301210204144715 |
Print ISSN 2589-9775 |
Publisher Name Bentham Science Publisher |
Online ISSN 2589-9783 |
6
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Microbial Biotransformation: Recent Developments on Steroid Drugs
Recent Patents on Biotechnology Non-coding RNAs: Cracking the Code for Clinical Disease
Current Neurovascular Research Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Recent Advances in 1,3,5-Triazine Derivatives as Antibacterial Agents
Mini-Reviews in Organic Chemistry Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Current Neurovascular Research Cardiac Mitochondrial Alterations Observed in Hyperglycaemic Rats - What Can We Learn From Cell Biology?
Current Diabetes Reviews Computational Studies Applied to Anti-inflammatory Drug Discovery: A Review
Current Organic Chemistry Elevated Levels of Bilirubin and Long-Term Exposure Impair Human Brain Microvascular Endothelial Cell Integrity
Current Neurovascular Research Current Management of Traumatic Rupture of the Descending Thoracic Aorta
Current Cardiology Reviews An Overview of Prospective Drugs for Type 1 and Type 2 Diabetes
Current Drug Targets Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders
Current Molecular Medicine Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Current Pharmaceutical Design An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy The Design and Development of Fesoterodine as a Prodrug of 5- Hydroxymethyl Tolterodine (5-HMT), the Active Metabolite of Tolterodine
Current Medicinal Chemistry Riboregulators and Metabolic Disorders: Getting Closer Towards Understanding the Pathogenesis of Diabetes Mellitus?
Current Molecular Medicine Alcohol Consumption and Risk of Uterine Fibroids
Current Molecular Medicine The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Current Cancer Drug Targets Subclassification and Nomenclature of α- and β-Adrenoceptors
Current Topics in Medicinal Chemistry Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics
Current Topics in Medicinal Chemistry